Netakimab is an anti-IL-17 monoclonal antibody. Nerelimomab can be used for research of ankylosing spondylitis, psoriatic arthritis, moderate-to-severe plaque psoriasis.
Purity:
>95.0%
CAS Number:
[1796570-08-5]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted